Compare Stocks

Enter up to ten stock symbols separated by a comma or space (ex. XOM,CVX,COP,BP,EQNR).

NYSE:XOM NYSE:CVX NYSE:COP NYSE:BP NYSE:EQNR

Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
COP ConocoPhillips	$89.32 +2.6%	$75.83	$39.70 ▼ $89.19	$117.81B	1.61	8.68 million shs	207,696 shs
XOM Exxon Mobil	$75.39 +1.6%	$64.80	$44.29 ▼ $76.00	$319.17B	1.36	30.10 million shs	990,862 shs
EQNR Equinor ASA	$28.21 -0.8%	$26.87	$17.60 ▼ $29.72	$91.58B	1.08	3.35 million shs	230,983 shs
CVX Chevron	$136.29 +2.7%	$119.85	$84.57 ▼ $134.71	$262.72B	1.28	14.06 million shs	625,888 shs
BP BP	$31.52 +0.1%	$28.13	$20.42 ▼ $32.64	$103.68B	0.87	15.45 million shs	687,927 shs

MarketRank™

Company	Overall Score	Analyst's Opinion	Community Rank	Dividend Strength	Company Ownership	Earnings & Valuation
COP ConocoPhillips	3.19 of 5 Stars	2.5	4.5	3.3	2.5	3.1
XOM Exxon Mobil	3.21 of 5 Stars	2.1	4.1	4.2	2.5	3.1
EQNR Equinor ASA	2.29 of 5 Stars	2.0	3.9	2.5	0.0	3.1
CVX Chevron	3.14 of 5 Stars	2.4	4.8	4.2	2.5	1.9
BP BP	2.67 of 5 Stars	2.3	4.7	3.3	0.0	3.1

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
COP ConocoPhillips	2.95	Buy	$86.32	-3.36% Downside
XOM Exxon Mobil	2.29	Hold	$67.61	-10.31% Downside
EQNR Equinor ASA	1.94	Hold	$29.92	6.06% Upside
CVX Chevron	2.74	Buy	$128.90	-5.42% Downside
BP BP	2.50	Buy	$32.28	2.41% Upside

Current Analyst Ratings

Latest XOM, CVX, COP, BP, and EQNR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
1/27/2022	COP ConocoPhillips	KeyCorp	Boost Price Target	Overweight	$91.00 ➝ $94.00
1/26/2022	EQNR Equinor ASA	Bank of America	Downgrade	Buy ➝ Neutral
1/25/2022	COP ConocoPhillips	Morgan Stanley	Boost Price Target	Overweight	$95.00 ➝ $96.00
1/25/2022	COP ConocoPhillips	Raymond James	Boost Price Target	Strong-Buy	$100.00 ➝ $107.00
1/25/2022	CVX Chevron	Morgan Stanley	Boost Price Target	Overweight	$155.00 ➝ $166.00
1/20/2022	COP ConocoPhillips	KeyCorp	Boost Price Target	Overweight	$88.00 ➝ $91.00
1/19/2022	XOM Exxon Mobil	Royal Bank of Canada	Upgrade	Underperform ➝ Sector Perform	$70.00 ➝ $90.00
1/18/2022	COP ConocoPhillips	The Goldman Sachs Group	Upgrade	Neutral ➝ Buy	$78.00 ➝ $101.00
1/18/2022	CVX Chevron	The Goldman Sachs Group	Boost Price Target	Neutral	$121.00 ➝ $146.00
1/18/2022	CVX Chevron	Raymond James	Boost Price Target	Outperform	$137.00 ➝ $155.00
1/18/2022	BP BP	Raymond James	Boost Price Target	Outperform	$33.00 ➝ $36.00

(Data available from 1/27/2019 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
COP ConocoPhillips	$19.26B	6.12	$4.52 per share	19.75	$27.95 per share	3.20
XOM Exxon Mobil	$181.50B	1.76	$11.07 per share	6.81	$38.82 per share	1.94
EQNR Equinor ASA	$45.82B	2.00	$4.84 per share	5.83	$10.44 per share	2.70
CVX Chevron	$94.69B	2.77	$10.80 per share	12.62	$71.08 per share	1.92
BP BP	$183.50B	0.57	$2.65 per share	11.90	$25.31 per share	1.25

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
COP ConocoPhillips	-$2.70B	$3.36	26.58	10.56	0.68	12.18%	11.87%	6.00%	2/3/2022 (Confirmed)
XOM Exxon Mobil	-$22.44B	-$1.39	N/A	12.18	0.81	-2.39%	8.66%	4.27%	2/1/2022 (Confirmed)
EQNR Equinor ASA	-$5.51B	$0.85	33.19	7.29	0.15	4.04%	17.98%	5.11%	2/9/2022 (Estimated)
CVX Chevron	-$5.54B	$5.18	26.31	13.88	2.91	7.10%	7.95%	4.42%	1/28/2022 (Confirmed)
BP BP	-$20.31B	$1.93	16.33	6.94	0.53	4.11%	9.89%	3.20%	2/8/2022 (Confirmed)

Latest XOM, CVX, COP, BP, and EQNR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
2/8/2022	N/A	BP BP	$1.19	N/A	-$1.19	N/A	N/A	N/A
2/3/2022	N/A	COP ConocoPhillips	$2.18	N/A	-$2.18	N/A	N/A	N/A
2/1/2022	N/A	XOM Exxon Mobil	$1.79	N/A	-$1.79	N/A	N/A	N/A
1/28/2022	N/A	CVX Chevron	$2.96	N/A	-$2.96	N/A	N/A	N/A
11/2/2021	9/30/2021	COP ConocoPhillips	$1.53	$1.77	+$0.24	$1.76	$11.34 billion	$11.62 billion
11/1/2021	9/30/2021	BP BP	$0.96	$0.99	+$0.03	$2.74	$39.23 billion	$37.87 billion
10/28/2021	9/30/2021	XOM Exxon Mobil	$1.56	$1.58	+$0.02	$1.59	$72.05 billion	$73.79 billion
10/28/2021	9/30/2021	CVX Chevron	$2.21	$2.96	+$0.75	$2.73	$40.89 billion	$44.71 billion

(Earnings results data provided by Zacks Investment Research)

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
COP ConocoPhillips	$1.95	2.18%	+68.10%	58.04%	5 Years
XOM Exxon Mobil	$3.52	4.67%	+8.05%	N/A	38 Years
EQNR Equinor ASA	$0.52	1.84%	-38.47%	61.18%	1 Years
CVX Chevron	$5.36	3.93%	+18.53%	103.47%	34 Years
BP BP	$1.29	4.09%	-47.11%	66.84%	1 Years

Latest XOM, CVX, COP, BP, and EQNR Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
1/26/2022	XOM Exxon Mobil	quarterly	$0.88	4.75%		2/10/2022	3/10/2022
1/26/2022	CVX Chevron	quarterly	$1.42	4.28%		2/16/2022	3/10/2022
12/6/2021	COP ConocoPhillips	Quarterly	$0.20	1.07%	12/31/2021	1/3/2022	1/14/2022
11/4/2021	BP BP	quarterly	$0.3276	4.6%	11/10/2021	11/12/2021	12/17/2021
10/27/2021	XOM Exxon Mobil	quarterly	$0.88	5.5%	11/10/2021	11/12/2021	12/10/2021
10/27/2021	CVX Chevron	quarterly	$1.34	4.78%	11/17/2021	11/18/2021	12/10/2021

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
COP ConocoPhillips	0.42	1.93	1.83
XOM Exxon Mobil	0.26	0.90	0.58
EQNR Equinor ASA	0.82	1.66	1.56
CVX Chevron	0.27	1.28	1.03
BP BP	0.67	1.16	0.84

Ownership

Institutional Ownership

Company	Institutional Ownership
COP ConocoPhillips	78.94%
XOM Exxon Mobil	51.71%
EQNR Equinor ASA	5.4%
CVX Chevron	64.98%
BP BP	8.78%

Insider Ownership

Company	Insider Ownership
COP ConocoPhillips	0.08%
XOM Exxon Mobil	0.05%
EQNR Equinor ASA	N/A
CVX Chevron	0.28%
BP BP	1%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
COP ConocoPhillips	9,700	1.32 billion	1.32 billion	Optionable
XOM Exxon Mobil	72,000	4.23 billion	4.23 billion	Optionable
EQNR Equinor ASA	21,245	3.25 billion	N/A	Optionable
CVX Chevron	47,736	1.93 billion	1.92 billion	Optionable
BP BP	68,100	3.29 billion	3.26 billion	Optionable

XOM, CVX, COP, BP, and EQNR Headlines

Source	Headline
	How Potassium Helps Lower Your Blood Pressure - Health Essentials from Cleveland Clinic health.clevelandclinic.org - January 27 at 8:25 AM
	PHOTOS: Southeastern/BP vs. South Shore Tech boys hockey - Enterprise News enterprisenews.com - January 27 at 1:40 AM
	Jio-bp expands with Delhi EV charging hub - The Hindu thehindu.com - January 26 at 3:40 PM
	Bronx BP and AT&T distributing free tablets to families impacted by Bronx apartment fire - Amsterdam News amsterdamnews.com - January 26 at 10:40 AM
	Ex-Dividend Reminder: BP Midstream Partners, Enterprise Products Partners and Targa Resources - Nasdaq nasdaq.com - January 26 at 10:40 AM
	EPA adds 1-bromopropane (1-BP) to the Clean Air Act List of Hazardous Air Pollutants - EIN News einnews.com - January 25 at 7:48 PM
	BP submits Government bids over major clean energy projects - Built Environment Networking built-environment-networking.com - January 25 at 2:48 PM
	Union faults BP's proposals in local refinery negotiations - Reuters reuters.com - January 25 at 8:28 AM
	Smartwatch blood pressure sensor technology is getting close - ZDNet zdnet.com - January 25 at 12:02 AM
	Hayfield boys take down BP - Austin Daily Herald - Austin Herald austindailyherald.com - January 25 at 12:02 AM
	Bronx BP talks fire survivors frustrated over delay in aid, gun violence and more - WPIX 11 New York pix11.com - January 24 at 7:02 PM
	Aker BP 2021 output just below full-year guidance - Yahoo Eurosport UK uk.sports.yahoo.com - January 24 at 7:02 PM
	Mooring of bp's Argos platform successfully completed - Offshore magazine offshore-mag.com - January 24 at 7:02 PM
	Aker BP 2021 output just below full-year guidance - FX Empire fxempire.com - January 24 at 2:01 PM
	SF Giants News: Giants selling spring training tickets, despite lockout - McCovey Chronicles mccoveychronicles.com - January 24 at 2:01 PM
	High Blood Pressure, BMI Tied to Greater Burden of Cerebral Small Vessel Disease - Neurology Advisor neurologyadvisor.com - January 24 at 2:01 PM
	Monday/Tuesday BP: Giants selling spring training tickets, despite lockout - Reverb MSN Music msn.com - January 24 at 9:00 AM
	Appeals Court Clears The Hartford on Most BP Oil Spill Cleanup Workers' Injury Claims - Claims Journal claimsjournal.com - January 21 at 3:05 PM
	Cumulative high BP exposure drives systolic, diastolic dysfunction in middle age - Healio healio.com - January 21 at 10:04 AM
	Appeals Court Revives BP’s Fight Over Deepwater Cleanup Workers’ Claims - MarineLink marinelink.com - January 20 at 7:26 PM
	Calumet Specialty Products and BP Prudhoe among Energy/Material gainers; Platinum Group Metals among losers - Seeking Alpha seekingalpha.com - January 20 at 2:22 PM
	Are analysts upbeat on the outlook for Bp? - Stockopedia stockopedia.com - January 20 at 8:28 AM
	PGS books carbon capture and storage related seismic work with BP and Equinor - Upstream Online upstreamonline.com - January 20 at 8:28 AM
	A Two-Step Method of Black Phosphorus Flake Thinning - AZoM azom.com - January 19 at 6:55 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.